CytoSorb device

DEVICE3 trials

Sponsors

CytoSorbents, Inc, Universitätsklinikum Hamburg-Eppendorf, Leiden University Medical Center

Conditions

Coronary Artery DiseaseHeart FailureHeart Valve DiseasesRhabdomyolysisVasoplegia

Phase 2

Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis

WithdrawnNCT02111018

CytoSorbents, IncRhabdomyolysis

Start: 2014-03-31Updated: 2023-04-07

Unknown Phase

Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery

CompletedNCT02297334

Universitätsklinikum Hamburg-EppendorfCoronary Artery Disease, Heart Valve Diseases

Start: 2013-09-30End: 2017-08-31Updated: 2017-08-29

Prevention of Low Blood Pressure After Cardiac Surgery in Heart Failure Patients With a Filter Called CytoSorb.

RecruitingNCT04812717

Leiden University Medical CenterHeart Failure, Vasoplegia

Start: 2021-10-27End: 2026-01-31Target: 36Updated: 2023-12-13

Related Papers

Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial

BMJ Open2022-09-015 citations